Surry Hills, Australia

Peter Whitfeld


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Peter Whitfeld

Introduction

Peter Whitfeld is an accomplished inventor based in Surry Hills, Australia. He has made significant contributions to the field of therapeutic and diagnostic agents through his innovative work. With a total of 3 patents, Whitfeld has focused on developing humanized antibodies that target the human C5a receptor.

Latest Patents

Whitfeld's latest patents include groundbreaking methods for inhibiting the interaction of C5aR with C5a using anti-C5aR antibodies. These inventions are directed towards humanized antibodies that bind to the human C5a receptor, which can be utilized as therapeutic and diagnostic agents. Additionally, his patents encompass nucleic acid sequences that encode these humanized antibodies and their expression in recombinant host cells. Notably, these humanized antibodies are derived from the murine antibody 7F3, which specifically binds to the human C5a receptor.

Career Highlights

Peter Whitfeld is currently associated with G2 Inflammation Pty Ltd, where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of inflammation and immune response.

Collaborations

Whitfeld collaborates with notable colleagues, including David Georges Zahra and Charles Reay Mackay, who contribute to his innovative projects and research initiatives.

Conclusion

Peter Whitfeld's contributions to the field of therapeutic and diagnostic agents through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…